Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-034490
Filing Date
2020-12-18
Accepted
2020-12-18 17:00:46
Documents
1
Period of Report
2020-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3519
  Complete submission text file 0000899243-20-034490.txt   4916
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Issuer) CIK: 0001496671 (see all company filings)

EIN.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CALITHERA BIOSCIENCES 343 OYSTER POINT BLVD, SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address
Orford Keith (Reporting) CIK: 0001670740 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36644 | Film No.: 201401315